Doximity Q1 revenue up 15%, beats analyst estimates

Doximity

07/08/2025 21:17

Overview

Doximity fiscal Q1 revenue rises 15% yr/yr, beating analyst expectations

Adjusted EPS for fiscal Q1 beats consensus, reflecting strong financial performance

Adjusted EBITDA up 21% yr/yr, surpassing analyst forecasts

Outlook

Doximity sees Q2 revenue between $157 mln and $158 mln

Doximity expects Q2 adjusted EBITDA between $87 mln and $88 mln

Doximity updates FY2026 revenue guidance to $628 mln-$636 mln

Doximity projects FY2026 adjusted EBITDA between $341 mln and $349 mln

Result Drivers

AI SUITE GROWTH - Doximity's AI suite grew fivefold year-over-year, driving revenue increase

PRESCRIBER ENGAGEMENT - Over 630,000 prescribers used workflow tools, enhancing service efficiency

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$145.91 mln
$139.50 mln (18 Analysts)
Q1 Adjusted EPS
Beat
$0.36
$0.3 (16 Analysts)
Q1 Net Income
$53.32 mln
Q1 Adjusted EBITDA
Beat
$79.80 mln
$71.60 mln (17 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 10 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the software peer group is "buy"

Wall Street's median 12-month price target for Doximity Inc is $65.00, about 10.6% above its August 6 closing price of $58.13

The stock recently traded at 39 times the next 12-month earnings vs. a P/E of 41 three months ago

Press Release: ID:nBw7nLN87a

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)